High-throughput cell-based assays are becoming a powerful approach in the drug discovery process. The ArrayScan™ highcontent screening (HCS) reader is a cytometer based on a fully automated fluorescence microscope that is able to obtain quantitative information on the intensity and localization of fluorescence signals within single cells over a wide cell population. The aim of this work was to set up an automated HCS multiparameter analysis for the quantification of the in vitro proliferation index of normal human dermal fibroblast (NHDF) cultures. The authors stimulated starved NHDF with insulin-like growth factor-1, platelet-derived growth factor, epidermal growth factor, fibroblast growth factor, or serum, and they quantified the proliferation index by measuring the expression of Ki-67 antigen, the incorporation of bromodeoxyuridine (BrdU), and the phosphorylation of the retinoblastoma protein (pRb). This approach also allowed quantification of the mitotic index by phospho-histone H3 staining and the percentage of cells in the S-phase by BrdU incorporation. The proliferation data from the ArrayScan™ assays were validated by comparison with a reference enzyme-linked immunosorbent assay (ELISA) and by flow cytometry. The measured proliferation indices were highly reproducible in repeated measures and independent experiments. The authors therefore propose that the ArrayScan™ HCS system could be used for high-throughput multiparameter analysis and quantification of the proliferation of cellular cultures. (Journal of Biomolecular Screening 2004:232-243) 
INTRODUCTION
H IGH-CONTENT SCREENING (HCS) employs fluorescent indicators to define cellular morphometry and molecular responses to compound treatment. The drug discovery process is greatly enhanced by multiparametric cellular analyses that define, often in a few multiplexed assays, the toxicity, potency, specificity, and selectivity of pharmacologically active compounds. Among the phases of the drug discovery process, a critical role belongs to the proliferation assays: cell proliferation analysis assumes relevant significance for both toxicological and pharmaceutical purposes. Because deregulated cell proliferation lies at the heart of all tumor development, 1 an evaluation of the in vitro proliferation in-dex by a multiparameter analysis is a desirable tool for oncological research purposes and, in general, to study every physiological or pathological process involving cell proliferation such as immune response, inflammation, tissue homeostasis, or angiogenesis. 2 Proliferating cells, unlike quiescent ones, are stimulated to progress through the cell cycle by internal or external stimuli, such as the presence of growth factors. An asynchronous growing cell population is composed of cells in all the phases of the cell cycle (G1, S, G2, and M). During exponential growth, the percentage of cells in each phase depends on the duration of the same phase with respect to the duration of the entire cell cycle. In the field of oncology, a wealth of data exists to support the use of certain drugs to induce a cell cycle block in specific phases. For example, taxol induces a late G2/M block via prevention of mitotic spindle assembly; 3 nocodazole completely blocks the self-assembly of tubulin, inducing a reversible block in the M-phase; 4, 5 and cells treated with hydroxyurea, a potent inhibitor of DNA synthesis, are blocked in the S-phase. 6 Quantifying the cell cycle subpopulations by HCS is a desired goal to screen chemical libraries or characterize the mode of action of new drugs.
At present, among the methods used for high-throughput cell proliferation detection, one of the most used is the quantification of bromodeoxyuridine (BrdU) incorporation by enzyme-linked immunosorbent assay (ELISA); 7 other methods include assays based on the total protein content quantification by sulforhodamine B (SRB) 8 or on adenosine triphosphate (ATP) bioluminescence as a measure of cell proliferation, 9 besides the more classical 3 H-thymidine incorporation assay. 10, 11 During the past decade, more sophisticated techniques for the cell-based analysis of proliferation emerged owing to improvements in the performances of personal computers. One of the earlier attempts to apply fluorescence image analysis to the study of the cell cycle was conducted by Danks and coworkers, 12 who set up a fluorescence digital imaging microscopy (FDIM) assay to determine the cell cycle position and both the content and the distribution of nuclear proteins, such as DNA topoisomerase I, in individual cells. Laser scanning cytometry (LSC), a technique based on a microscope cytofluorimeter, 13 was also used for cell proliferation analysis purposes. [14] [15] [16] At present, few techniques allow a highcontent analysis of cell proliferation at the single cell level and simultaneous acquisition of morphological data.
The ArrayScan™ high-content screening system (Cellomics, Pittsburgh, PA) is a cytometer based on a fully automated fluorescence microscope that acquires images from cells seeded in multiwell plates. 17 This instrument performs automated measurements, including the intensity and the localization of the fluorescence signals within single cells and within subcellular compartments over a wide cell population. The image analysis is performed in real time for up to 4 fluorescence channels. The ArrayScan™ has been recently used to analyze the execution of several cellular events that can be tracked by fluorescence immunocytochemistry, such as variations in cellular morphology 18 and intracellular trafficking, 19 or to characterize NF-κB nuclear translocation. 20 This "cell-centric" approach opens a new frontier in the high-throughput screening (HTS) of pharmaceutical compounds and lead optimization. 21, 22 The main advantage of such an approach resides in the possibility of acquiring both intrinsic data (for individual cells) and population data within a single analysis.
Here we describe a novel automated, multiparametric HCS assay based on the ArrayScan™ 4.0 system to determine the cell proliferation index and to quantify the M-phase and S-phase indices in adherent cellular cultures. The proliferation index, defined as the percentage of proliferating cells in a population, is a very important parameter to evaluate the in vitro stimulation potency of growth factors and the antiproliferative activity of drugs. The detection of blocks in specific cell cycle phases is also relevant to study the mechanism of action of drugs; in particular, this novel approach allows the quantification of the mitotic index, defined as the percentage of cells in the M-phase and in the S-phase within a single measure.
We stimulated starved normal human dermal fibroblast (NHDF) cells, a well-characterized experimental model, 23 with several growth factors (insulin-like growth factor-1 [IGF-1], epidermal growth factor [EGF], platelet-derived growth factor [PDGF], basic fibroblast growth factor [bFGF]) or serum and fol-lowed 4 biological markers of cell proliferation. Bromodeoxyuridine (BrdU) incorporation, histone H3 phosphorylation, Ki-67 protein (pKi-67) expression, and retinoblastoma protein (pRb) phosphorylation were quantified using fluorescent indicators and HCS. Growing cells duplicate their DNA during the Sphase: BrdU is a nucleotide analog of thymidine, which is incorporated during the synthesis of DNA and can be easily detected with commercial antibodies. The BrdU incorporation assay is one of the most common methods to detect DNA synthesis and proliferation in histological or cytological samples. 24 In quiescent cells, histone H3 contributes to DNA packaging in chromatin. When cells enter the M-phase and chromosomes start to condense, histone H3 is phosphorylated, owing to the action of specific cell cycle-dependent kinases. Thus, histone H3 phosphorylation represents a wellcharacterized biological marker of the M-phase. 25 The human Ki-67 antigen is ubiquitously expressed in the nucleus during cell cycle progression, and thus it is commonly used as a proliferation marker. 26 It has been suggested that pKi-67 could be a Ran-associated protein involved in the disintegration and reformation of the nucleolus. 27 The Rb protein was identified as a tumor suppressor protein inactivated in several tumors, such as retinoblastoma; 28 pRb plays a crucial role in cell cycle regulation and apoptosis. 29 Unphosphorylated Rb interacts with the members of the E2F family of transcription factors in quiescent cells and inhibits the transcription of genes involved in cell cycle progression. 30 In fact, progression through the G1-to S-phase requires the sequential phosphorylation of pRb by CDK-cyclin complexes, which eventually results in its inactivation and release of active E2F. 31 We thus followed pRb phosphorylation as a marker of cell proliferation with anti-phospho-Rb (Ser807/811) specific antibodies.
After stimulating cells with serum or growth factors for 24 h, at least 1600 cells were analyzed on the ArrayScan™, and the percentage of positive stained cells was expressed as the proliferation index or mitotic index. We observed an overall increase of BrdU incorporation, Ki-67 expression, pRb phosphorylation, and histone H3 phosphorylation in stimulated cells in comparison with starved cells, confirming that stimulated cells were cycling. Importantly, we found that the proliferation index obtained from BrdU incorporation, pRb phosphorylation, and Ki-67 expression was consistent and reliable. We demonstrated that the ArrayScan™ system can be successfully applied to the high-content analysis of cell proliferation, as further confirmed by a reference ELISA method. Moreover, we demonstrated that this approach also allows quantification of cell cycle populations in the S-phase and M-phase.
MATERIALS AND METHODS

Chemicals
IGF-1 was a kind gift of Magnus Magnusson (Pharmacia, Sweden); EGF, PDGF, and BrdU were obtained from Roche Diagnos-tics Corporation (Basel, Switzerland); recombinant bFGF was produced in house, as previously described; 32 murine anti-BrdU monoclonal antibody (clone B44) was obtained from Beckton Dickinson (San Jose, CA); murine anti-Ki-67 monoclonal antibody (clone MIB-5) was obtained from DAKO (Glostrup, Denmark); rabbit anti-phospho-Rb (Ser 807/811) antibody was obtained from Cell Signaling Technology (Beverly, MA); phosphorylated histone H3 was detected by using the primary rabbit antibody in the Mitotic Index HitKit (Cellomics, Pittsburgh, PA); Fluorolink™ Cy2™ (λ max excitation: 489 nm; λ max emission: 506 nm)-labeled goat anti-mouse antibody, Fluorolink™ Cy2™-labeled goat anti-rabbit antibody, and Fluorolink™ Cy3™ (λ max excitation: 554 nm; λ max emission: 566 nm)-labeled goat anti-rabbit antibody were obtained from Amersham Pharmacia Biotech (Little Chalfont, Buckinghamshire, UK); and 4,6diamidino-2-phenylindole (DAPI) (λ max excitation: 359 nm; λ max emission: 461 nm) was obtained from Sigma-Aldrich (St. Louis, MO).
Cell culture and treatment
NHDF, obtained from PromoCell (Heidelberg, Germany), were seeded in complete medium at 50,000 cells/cm 2 and cultured for 5 days. Complete medium (Fibroblast Growth Medium, PromoCell, Germany) contains 50 ng/mL amphotericin B, 50 µg/ mL gentamicin, 5 µg/mL bovine insulin, 10% v/v heat-inactivated fetal bovine serum (Gibco BRL, USA), and 5 ng/mL recombinant bFGF. Cells were detached using a trypsin/ ethylenediaminetetraacetic (EDTA) solution, collected in the basal medium plus 5% fetal bovine serum, and washed twice in serumfree medium. Cells were then resuspended in basal medium containing 0.1% bovine serum albumin (BSA) (Sigma-Aldrich, St. Louis, MO) and seeded in 96-well black plates (VewPlate™-96, plate number 6005182, Packard, CT) at a final density of 5 × 10 3 cells/well. Proliferation was inhibited by serum starvation for 4 days. NHDF were then alternatively stimulated with the following growth factors: 10 nM IGF-1, 1 nM bFGF, 10 nM EGF, 10 nM PDGF, or 10% fetal bovine serum. Because the activity of the growth factors varies depending on the lot, we previously performed a dose-response activity assay to determine the maximal effective concentrations (not shown). Cells were cultured for 24 h at 37°C in a humidified atmosphere with 5% CO 2 before fixation.
Cell proliferation ELISA assay
To evaluate DNA synthesis, 50 µM BrdU was added to the medium 4 h before fixation, and then samples were processed using a cell proliferation ELISA kit (Roche Diagnostics, Basel, Switzerland) according to the manufacturer's instructions. The BrdU incorporation was then quantified by colorimetric immunoassay at 450 nm by an automated microplate reader (model Elx808, Bio-Tek Instruments, VT), following kit instructions. The absorbance background signal measured was subtracted from all the values reported.
Flow cytometry
For flow cytometric analysis of DNA content, cells were detached with the trypsin/EDTA solution and fixed with 70% ethanol for 30 min. Fixed cells were washed in phosphate-buffered saline (PBS) and resuspended in a staining solution containing 25 µg/mL propidium iodide in 0.1% sodium citrate, 0.1% Nonidet P40, and 12.5 µL ribonuclease (RNase) 1 mg/mL. Cells were incubated for 30 min in the dark and analyzed using a FACScan equipped with a Xe/Ne laser at 488 nm (Beckton Dickinson, Franklin Lakes, NJ). Cell cycle populations in the G1-, S-, and G2/M-phases were quantified with the software ModFit LT v3.0, purchased from Verity Software House (Topsham, ME).
Fluorescence immunocytochemistry
For the Ki-67 protein, phospho-histone H3, and phospho-Rb immunostaining, NHDF were stimulated for 24 h and then fixed in 3.7% formaldehyde for 20 min. Cells were washed with PBS and permeabilized with 0.5% Triton X-100 (Sigma-Aldrich, St. Louis, MO) in PBS for 15 min. After washing with PBS, the primary antibody was added at the recommended dilution in PBS containing 1% BSA and 0.3% Tween-20 (Sigma-Aldrich, St. Louis, MO) for 1 h at 37°C. The primary antibody solution was removed, and cells were washed twice with PBS. Antiprimary Cy2™-conjugated secondary antibody was added at the recommended dilution in PBS containing 1% BSA and 0.3% Tween-20 for 1 h at 37°C. The secondary antibody solution was removed, and cells were counterstained with DAPI for 2 min in the dark and washed with PBS, leaving 200 µL in each well. For anti-BrdU immunostaining and for anti-BrdU/anti-phospho-histone H3 coimmunostaining, 50 µM BrdU was added to the medium 4 h before fixation, and then cells were fixed in ice-cold absolute ethanol for 15 min and washed twice with PBS. For DNA denaturation, 100 µL of absolute HCl diluted 1:6 in PBS was added to each well. After a 20-min incubation, cells were washed twice, and antibodies were added as previously described.
Automated image capture and analysis
The ArrayScan™ 4.0 system (Cellomics, Pittsburgh, PA) was used to screen for mitotic and proliferation data. The system is based on an inverted epifluorescence microscope (Zeiss, Thornwood, NY) equipped with a 200-W mercury-xenon lamp; the instrument automatically focuses samples and scans fields by means of a motorized stage. The images were acquired with a high-resolution, thermoelectrically cooled 12-bit charge-coupled device (CCD) camera by exposing the samples for a constant time. A quadruple-band fluorescence excitation filter (model XF93, Omega Optical, Brattleboro, VT) was used to acquire the fluorescence in the Hoechst/DAPI channel (365WB50), in the green channel (475RDF40), and in the red channel (560DF15). Cells seeded in black 96-well plates were located by means of nuclear fluorescence, which is accepted or rejected in an automated man-ner based on the nuclear area and shape, the fluorescence intensity, and the position of the nucleus in the field. The parameters set for nuclei recognition ensured that any artifacts or cell clusters were absent in the populations analyzed. The images were automatically stored and analyzed by the ArrayScan™ software; the mitotic index algorithm (Cellomics, Pittsburgh, PA) was used to count the total cell number (as fluorescent nuclei) and cells positively stained. At least 15 fields were analyzed in each well with a ×10 objective, corresponding to at least 1600 cells counted. For double-staining experiments, the Apoptosis 1 algorithm (Cellomics, Pittsburgh, PA) was used to acquire fluorescence microphotographs in the DAPI, green, and red channels. An analysis of the fluorescence intensity distribution was performed for anti-BrdU-and anti-phospho-Rb-stained samples by analyzing 1000 cells with the cytoplasm-to-nucleus translocation algorithm (Cellomics, Pittsburgh, PA). For each cell, the nuclear area and the average nuclear intensity value in the target channel (NucInten (TargetCh)) were collected and subsequently processed by an Excel macro (Microsoft, USA) developed by the authors. The entire fluorescence range (1-4095) was subdivided into 800 bins.
RESULTS AND DISCUSSION
Serum or growth factors stimulate NHDF proliferation
An ELISA for BrdU incorporation was chosen as a reference method to quantify the cell proliferation index to compare the ArrayScan™ results. NHDF cells were plated in black 96-well plates at a final density of 1.4 × 10 4 cells/cm 2 and starved for 4 days by serum deprivation. Starved NHDF cells were stimulated with IGF-1, PDGF, EGF, bFGF, or 10% fetal bovine serum for 24 h (see Materials and Methods for details). Because the stimulation potency of different growth factors varies, dose-response ELISAs for BrdU incorporation were performed to evaluate the proliferative effect of each growth factor (data not shown). The first concentration value at which the dose-response curve was reliably maximal in diverse tests was selected for our experiments. In Figure 1 , we show the results corresponding to cell proliferation ELISA on starved NHDF cells or stimulated with 10 nM IGF-1, 1 nM bFGF, 10 nM EGF, 10 nM PDGF, or 10% fetal bovine serum.
The optical density at 450 nm (OD 450 nm ) corresponding to starved cells remained below 0.04 units (±0.01, n = 8), confirming that DNA synthesis was not active in these cells. In serum-induced proliferating cells, the OD 450 nm measured was about 0.52 units (±0.06, n = 4), more than 10-fold higher than observed with starved cells, confirming that NHDF efficiently enter DNA synthesis in response to serum stimulus. Values similar to those obtained for cells stimulated with serum were found for cells stimulated with PDGF or FGF (0.50 ± 0.08 and 0.50 ± 0.04, n = 8, respectively): the results confirm that PDGF and bFGF potently induce NHDF to proliferate, as previously reported. 33, 34 Following treatment with EGF and IGF-1, the absolute amount of DNA synthesis was lower: the OD measured were 0.31 (±0.02, n = 8) and 0.21 (±0.03, n = 8), respectively, suggesting that EGF and IGF-1 stimulate NHDF proliferation, as already reported, [35] [36] [37] but less potently than PDGF or bFGF at the concentrations and times investigated.
Quantification of the cell proliferation index and the mitotic index of starved or growing NHDF cultures by ArrayScan™
We then analyzed and quantified the proliferation of human fibroblast (NHDF) cultures stimulated with several growth factors or serum by a novel approach based on immunofluorescence and image analysis with the ArrayScan™ 4.0 cytometer. The proliferation index was quantified by immunodetection of Ki-67 antigen expression, Rb protein phosphorylation, and BrdU incorporation. The percentage of cells in the M-phase (the "mitotic index") was also quantified by phospho-histone H3 detection.
After fixation, cells were immunostained with specific antibodies (see Materials and Methods), and fluorescence images were collected and analyzed by the ArrayScan™ 4.0 system. All targets localize within the nucleus, and therefore they were easily detected by colocalization with the DAPI fluorescence using the mitotic index algorithm (Cellomics, Pittsburgh, PA), which allows the counting of cells whose target fluorescence intensity signal is over a fixed threshold. At least 15 fields were analyzed in each well, corresponding to 1600 to 2100 cells. In Figure 2 , we report representative images acquired in the DAPI and in the green (Cy2™) fluorescence channels of starved or growing NHDF stained for Ki-67 antigen, phospho-Rb, BrdU, and phospho-histone H3.
The results obtained from detection of pRb phosphorylation, Ki-67 expression, and BrdU incorporation confirmed that in starved NHDF cells, the proliferation index was at baseline levels, ranging from 4.5% to 6.5%, independent of the proliferation marker (Fig. 3A) . As further confirmation of this quiescent state, only 0.1% of these cells were positive for phospho-histone H3 (Fig. 3B) .
Conversely, fibroblasts stimulated with 10% serum were highly proliferative. We observed that 87% of the cells were positive for BrdU staining, 97% were positive for Ki-67 expression, and 100% of cells contained phosphorylated Rb protein (Fig. 3A) . The mitotic index of these cells was about 4% (Fig. 3B) . Although the mitotic index obtained for IGF-1, PDGF, and EGF had low statistical significance, as confirmed by the Student's t-test (Fig. 3B) , the increase of the phospho-histone H3 signal in these samples was clear, in comparison with starved cells. Because the percentage of cells in each cell cycle phase in exponentially growing asynchronous cell populations depends on the duration of that particular phase in comparison with the duration of the entire cell cycle, we should expect 2% to 4% of NHDF cells being in the M-phase. 38 Indeed, we observed that the percentage of phospho-histone H3positive cells was 3.2% ± 0.6% of the total proliferating cells for all stimuli (growth factors or serum) in the experimental conditions investigated. In the case of IGF-1, for example, about 20% of cells were proliferative; among these, 3.2% were in the M-phase, which corresponded to 0.6% of the overall cell population. This means that the conditions set up with this approach allowed the detection of signal increases below 1%, although not statistically significant with the number of replicates considered, with respect to nonproliferating starved cells.
Following treatment with growth factors, the proliferation indexes obtained from Ki-67, BrdU incorporation, or phospho-Rb detection were reciprocally in accord and were consistent with the mitotic index assessed by phospho-histone H3 immunostaining (Fig. 3A,B ). We found that IGF-1 stimulated about 20% of the fibroblasts to proliferate; PDGF induced the proliferation of about 57% of the cells (between 54.7% and 59.4%). Following stimulation with EGF, the proliferation index was between 43% and 48%, and following stimulation with bFGF, it was between 76.5% and 82.3%. Importantly, proliferation indexes obtained measuring each of the 3 markers were consistent over a wide range (between 4.5% and 100% positive cells) and highly reproducible in repeated measures and different experiments. Moreover, all proliferation data were consistent with the mitotic index resulting from phospho-histone H3 analysis (Fig. 3A,B) .
To validate the ArrayScan™ cytometric assay, we plotted the optical densities (OD 450 nm ) resulting from the ELISA experiments shown in Figure 1 against the proliferation index values obtained from BrdU incorporation using the ArrayScan™ (Fig. 4) . The correlation between the results obtained from the 2 methods was significant (linear correlation coefficient = 0.910). We therefore propose that the ArrayScan™ HCS system can be a successful approach for the high-throughput analysis and quantification of the proliferation of cellular cultures.
Cytometric fluorescence distribution analysis with the ArrayScan™ HCS system
The proliferation index or the mitotic index calculations described above are an aggregated analysis: we reanalyzed the same samples performing a segregated analysis to evaluate the overall The proliferation index was quantified in normal human dermal fibroblast (NHDF) cells starved or stimulated with 10 nM insulinlike growth factor-1 (IGF-1), 1 nM basic fibroblast growth factor (bFGF), 10 nM epidermal growth factor (EGF), 10 nM platelet-derived growth factor (PDGF), or 10% v/v fetal bovine serum by the ArrayScan™ system. Ki-67 antigen expression, pRb phosphorylation, and bromodeoxyuridine (BrdU) incorporation (A) were quantified as proliferation markers (mean ± standard deviation of at least 6 replicates). The mitotic index was also measured by immunostaining with anti-phosphohistone H3 antibody (B) (mean ± standard deviation of at least 6 wells are shown). Image analysis was performed with the ArrayScan™ software and the mitotic index algorithm (Cellomics, Pittsburgh, PA). *p < 0.05. **p < 0.005. Figure 1 were plotted against the proliferation indexes calculated for the same samples by the ArrayScan™ system on bromodeoxyuridine (BrdU) incorporation (shown in Fig. 3 ). The respective standard deviations were reported as horizontal and vertical bars (R: linear correlation index). fluorescence intensity distribution in populations of either starved or stimulated cells. We developed a method to process the fluorescence data at the single cell level from the ArrayScan™ software and to combine them in a fluorescence distribution histogram, reminiscent of the data representation format commonly used for flow cytometry. We reanalyzed BrdU incorporation and pRb phosphorylation to evaluate the importance of the threshold setting on the proliferation index and to study any correlation between the number of positive stained cells and their mean fluorescence intensity. In particular, we asked whether an increase of positive cells corresponded to an effective increase of the mean fluorescence intensity or whether these 2 parameters were independent. For each sample, 1000 NHDF cells were analyzed with the cytoplasm-tonucleus translocation algorithm (Cellomics, Pittsburgh, PA), which measures the nuclear area and the fluorescence intensity in the nucleus of each cell (expressed as the mean target fluorescence intensity of the pixels recognized as nuclear). The entire fluorescence range (1-4095) was subdivided into 800 bins. Figure 5A shows the fluorescence distribution histograms corresponding to BrdU incorporation, and Figure 5B shows those corresponding to pRb phosphorylation for starved or stimulated NHDF cells. The curves represent integrated data, whereas the inserts show the individual data points. For both proliferation markers, the negative (unstained) cells appear as peaks centered at about 220-240; positively stained cells are represented by symmetric, bell-shaped bands at higher fluorescence intensities. We integrated the total histogram areas and applied a threshold on the fluorescence (represented by a dotted line in the graphs) to quantify the area corresponding to positive cells. Because the cells were immunostained in saturating conditions, we assumed that the fluorescence intensity was proportional to the amount of the target in the nucleus. The proliferation indices indirectly obtained from area integration (Fig. 5A,B) were in accord with those measured by cell count (see Fig. 3 and Table 1 
for comparison).
We observed some intriguing effects on the maximum peak of the fluorescence intensity of positively stained cells, depending on whether the cells were stimulated with serum or growth factors. NHDF cells positively stained with anti-BrdU antibodies showed a mean fluorescence of about 420 following stimulus with EGF or PDGF, although a clear peak value was not apparent (Fig. 5A) . A clear fluorescence peak centered at about 400 appeared following stimulus with bFGF; for cells stimulated with 10% serum, the fluorescence peak was centered at about 380 (Fig. 5A) . For cells stained with anti-phospho-Rb antibodies, we observed that the maximum peak fluorescence value was centered at about 700 following stimulation with PDGF or EGF. The maximum of the fluorescence peak shifted respectively to 800 or to about 900 for bFGF and serum, respectively (Fig. 5B) . Taken together, these data indicate that the average fluorescence of stained nuclei varies depending on the stimulus, but this is not clearly related to the percentage of positive cells. Further work will clarify the biological meaning of these observed changes in nuclear intensity profiles.
The inserts in the graphs in Figures 5A and 5B are the dot plots of the nuclear fluorescence intensities versus the nuclear areas (in pixels) for each single cell, calculated for the corresponding histogram. Unstained cells can be easily recognizable as flattened dot clouds at the bottom, whereas stained fluorescent cells appear in the upper region. We compared these 2 parameters to monitor unexpected effects of nuclear morphology on the nuclear intensity distribution. It is clear that they did not show significant correlations: the mean nuclear area of unstained cells is similar to that of stained cells. Moreover, no linear correlation between nuclear size values and nuclear fluorescence intensity values was observed for stained cells, further confirming that the fluorescence intensity distribution depended only on the absolute nuclear fluorescence and not on cell shrinkage or other nuclear morphological artifacts.
Quantification of S-phase and M-phase cell populations with the ArrayScan™ HCS system
The possibility offered by this technique to detect distinct biomarkers in the same sample within a single measurement was exploited to quantify cell cycle populations. Proliferative asynchronous NHDF cells were seeded in 96-well plates and starved by serum deprivation. At 30 min before fixation, 50 µM BrdU was added to the medium. The percentages of cells in the S-phase and M-phase were measured by ArrayScan™ after anti-BrdU/antiphospho-histone H3 double staining; the same samples were analyzed by flow cytometry to quantify the cell cycle populations on the basis of the DNA content as a reference method to compare the ArrayScan™ results.
For each treatment, the cells present in 10 wells were collected, put together, and processed for flow cytometric analysis of the DNA content (propidium iodide staining), as described in Materials and Methods. Cells growing in the presence of serum displayed the typical DNA content distribution of asynchronous cell populations: 39 a high G1-phase peak, a smaller G2/M peak, and an S- The percentage of positively stained cells for BrdU incorporation and for pRb phosphorylation (corresponding to Fig. 3A) was compared with the percentage of the integrated area above the threshold (corresponding to Fig. 5 ). BrdU, bromodeoxyuridine; IGF-1, insulin-like growth factor-1; FGF, fibroblast growth factor; EGF, epidermal growth factor; PDGF, platelet-derived growth factor. phase population between them (Fig. 6A) . Following serum starvation, the G1-phase peak was the only prominent feature ( A B software to quantify the percentages of cells in the G1-, S-, and G2/ M-phases: in asynchronous growing fibroblasts, about 46% of the cells were in the G1-phase, about 38% were in the S-phase, and about 17% were in G2/M-phases (Fig. 6B) . In starved cells, the G1-phase subpopulation was more than 90% of the total, and low percentages were found in the other phases (about 6% and 4% in S and G2/M, respectively) (Fig. 6B) .
The same samples were analyzed with ArrayScan™, after fixation and coimmunostaining with anti-BrdU and anti-phosphohistone H3 antibodies. A secondary Cy2™-conjugated anti-mouse antibody was used to detect phospho-histone H3, and a secondary Cy3™-conjugated anti-mouse antibody was used for the staining of BrdU. The acquired images were analyzed with the mitotic index algorithm (Cellomics, Pittsburgh, PA) to quantify the fluorescence associated with BrdU (in the green channel) and that associated with phospho-histone H3 (in the red channel). Representative fields are shown in Figure 6C : in proliferative cells, but not in starved cells, fluorescence signals were detected for both BrdU incorporation and for histone H3 phosphorylation. Figure 6D shows the percentages of BrdU and phospho-histone H3 positively stained cells obtained by ArrayScan™: in starved NHDF cells, these percentages were negligible (0.2% and 0.1% for BrdU incorporation and for phospho-H3, respectively). In asynchronous growing NHDF, the percentage of cells positive for BrdUassociated fluorescence was 35.2% (±3.0%, n = 3), coincident with the S-phase index obtained from flow cytometry (37.6% ± 3.5%, n = 3) ( Fig. 6B) , demonstrating that 30 min of BrdU incorporation was a suitable time to quantify the cells in the S-phase with the ArrayScan™ HCS system. The percentage of positively stained cells for phospho-histone H3 was 3.3% ± 0.2% (n = 3), in accord with the mitotic index previously measured in cells growing in the presence of serum (see Fig. 3B ).
The values of both BrdU incorporation and the histone H3 phosphorylation obtained from ArrayScan™ analysis of doublestained samples were similar to those obtained from the single BrdU and phospho-H3 stainings of the same samples (data not shown), indicating that the staining of each marker did not interfere with the staining of the other.
CONCLUSIONS
The evaluation of the in vitro proliferation index of a given cell population by multiparameter analysis plays a crucial role in the study of new potential antitumoral drugs. The analysis of several distinct markers in the same cell population can greatly aid the discovery of stage-specific cell cycle inhibitors, for example, distinguishing between G0/G1-, S-, or M-phase inhibitors. Here, we have used growth factor-stimulated cell cycle progression in human fibroblasts as a model system for cell proliferation and demonstrated the differential effects of various stimuli on the proliferation index of these cells using an automated system.
The biology of the proliferative response is very complex and involves the activation of several pathways (i.e., receptor-initiated signal transduction, kinase activation, target phosphorylation, DNA synthesis, etc.), which are usually inactive in quiescent cells. The "high-content" approach of this novel cell proliferation assay allows simultaneously detecting the activation of distinct biomarkers, each belonging to different pathways. The 4 markers analyzed (Ki-67, BrdU, phospho-Rb, and phospho-histone H3) represent well-characterized biomarkers specific for both total proliferative cells (Ki-67, phospho-Rb, and BrdU 4-h incorporation) or for specific cell cycle populations (phospho-histone H3 for M-phase, BrdU 30-min incorporation for S-phase). An important advantage deriving from the HCS approach is that each proliferation marker can be interpreted together with the others or separately: different immunostainings could be combined in several ways in the same sample (Ki-67 plus phospho-Rb, Ki-67 plus BrdU, phospho-Rb plus BrdU, etc.). We combined phosphohistone H3 and BrdU stainings to simultaneously quantify the Sphase and the M-phase, but up to 3 nuclear markers (corresponding to 4 available fluorescence channels, including DAPI) may be evaluated together with the ArrayScan™ system.
The proliferation data from the ArrayScan™ assays were validated by comparison with a reference ELISA assay; the sensitivity and the accuracy of this novel method were high. Moreover, the quality of data was improved by the fact that results were not affected by the maximal fluorescence response, as for ELISA, and by the fact that the presence of false positives, deriving, for example, from the accidental presence of noncellular fluorescence particles in wells, was minimized (see also Simpson et al. 18 ). The proliferation levels measured by BrdU incorporation, pRb phosphorylation, and Ki-67 antigen expression were universally consistent within a wide range of absolute values (between 4.5% and 100% positive cells) and were highly reproducible in repeated measures and different experiments. Moreover, all proliferation data were found in accord with the mitotic index resulting from phospho-histone H3 analysis. The use of the proliferation markers described above constitutes a strong internal control because they are molecular readouts of distinct cell proliferation pathways: combined, they represent a multiparameter assay of cell proliferation. Moreover, by shortening the time of BrdU incorporation (30 min), it was possible to quantify the percentage of cells in the Sphase: in association with anti-phospho-histone H3 staining, this approach could be useful to detect specific cell cycle blocks in the S-or M-phase. An important advantage of this technique is that cell loss due to cytotoxicity inherent to many test compounds does not bias the population study and that the fraction of responsive cells can be accurately assessed.
The ArrayScan™ system is capable of cell populations analysis. As a demonstration of this, we analyzed fluorescence intensity distribution of cell populations stained for BrdU incorporation and phospho-Rb. The possibility of setting a fluorescence threshold to score for positively stained cells would be, per se, a strong reason to use this novel approach because it implies that the readout of such an assay is a percentage of positive cells rather than a mean fluorescence value, as for ELISA. An additional advantage of such analysis is the direct visualization of the distribution of staining intensity, allowing ad hoc choice of threshold values for the analysis in a fluorescence window. This approach could be used, for example, to discriminate drug effects on cells expressing different levels of a given target in different phases of the cell cycle.
We therefore propose that the ArrayScan™ HCS system is a valid technical approach for the analysis of the cell cycle and for the quantification of the proliferation index of mammalian cell cultures.
